Prevention of overweight and obesity in adult populations: a systematic review

Background The prevalence of normal-weight adults is decreasing, and the proportion in excessive weight categories (body mass index ≥ 25) is increasing. In this review, we sought to identify interventions to prevent weight gain in normal-weight adults. Methods We searched multiple databases from Jan...

Full description

Saved in:
Bibliographic Details
Published inCMAJ open Vol. 2; no. 4; pp. E268 - E272
Main Authors Peirson, Leslea, PhD, Douketis, James, MD, Ciliska, Donna, PhD, Fitzpatrick-Lewis, Donna, MSc, Ali, Muhammad Usman, MD, MSc, Raina, Parminder, PhD
Format Journal Article
LanguageEnglish
Published Canada Canadian Medical Association 01.10.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background The prevalence of normal-weight adults is decreasing, and the proportion in excessive weight categories (body mass index ≥ 25) is increasing. In this review, we sought to identify interventions to prevent weight gain in normal-weight adults. Methods We searched multiple databases from January 1980 to June 2013. We included randomized trials of primary care–relevant behavioural, complementary or alternative interventions for preventing weight gain in normal-weight adults that reported weight change at least 12 months after baseline. We included any studies reporting harms. We planned to extract and pool data for 4 weight outcomes, 6 secondary health outcomes and 5 adverse events categories. Results One small study provided moderate-quality evidence. The 12-month program, which used education and financial strategies and was offered more than 25 years ago in the United States, was successful in stabilizing weight and producing weight loss. More intervention participants maintained their baseline weight or lost weight than controls (82% v. 56%, p &spilt; 0.0001), and program participants maintained their weight better than controls by showing greater weight reduction by the end of the intervention (mean difference adjusted for height –0.82, 95% confidence interval –1.57 to –0.06, kg). No evidence was available for sustained effects or for any other weight outcomes, secondary outcomes or harms. Interpretation We were unable to determine whether behavioural interventions led to weight-gain prevention and improved health outcomes in normal-weight adults. Given the importance of primary prevention, and the difficulty of losing weight and maintaining weight loss, this paucity of evidence is surprising and leaves clinicians and public health practitioners with unclear direction. Registration: PROSPERO no. CRD42012002753
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Funding:The Canadian Institutes of Health Research provided funding for this review but had no role in the design, analyses, interpretation or decision to submit the paper for publication.
Competing interests:James Douketis has participated in advisory boards for Bayer, Bristol-Myers-Squibb, Sanofi, AstraZeneca, Boehringer Ingelheim, Pfizer, Biotie, Portola and The Medicines Company; has consulted for Agen Biomedical, Ortho-Janssen Pharmaceuticals and Boehringer Ingelheim; has received grant support from Boehringer Ingelheim. No competing interests were declared by the other authors.
Contributors:Leslea Peirson, Donna Ciliska, James Douketis, Donna Fitzpatrick-Lewis and Parminder Raina contributed to the conceptualization, data interpretation, writing and manuscript review. Leslea Peirson, Donna Ciliska and Donna Fitzpatrick-Lewis contributed to the methods, data collection and project coordination. Muhammad Usman Ali performed the data analysis and contributed to writing and manuscript review. All of the authors approved the version submitted for publication and agree to act as guarantors of the work.
ISSN:2291-0026
2291-0026
DOI:10.9778/cmajo.20140019